Alzinova AB (publ) (STO:ALZ)
Sweden · Delayed Price · Currency is SEK 0.5880
-0.0010 (-0.17%)
At close: Mar 27, 2026
Alzinova AB Market Cap
Alzinova AB has a market cap or net worth of 91.12 million as of March 27, 2026. Its market cap has decreased by -62.70% in one year.
Market Cap
91.12M
Enterprise Value
91.60M
Revenue
26.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.59
Market Cap Chart
Since November 25, 2015, Alzinova AB's market cap has increased from 57.35M to 91.12M, an increase of 58.88%. That is a compound annual growth rate of 4.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 91.12M | 5.36% |
| Dec 30, 2025 | 86.48M | -71.97% |
| Dec 30, 2024 | 308.51M | 128.27% |
| Dec 29, 2023 | 135.15M | 50.50% |
| Dec 30, 2022 | 89.80M | -11.61% |
| Dec 30, 2021 | 101.60M | -13.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 124.15M |
| Active Biotech AB | 114.67M |
| Alligator Bioscience AB | 106.53M |
| Biovica International AB | 105.09M |
| Annexin Pharmaceuticals AB | 98.12M |
| Scandinavian ChemoTech AB | 96.73M |
| Biosergen AB | 85.01M |
| Magle Chemoswed Holding AB | 81.77M |